Thomas N. Seyfried is Professor of Biology at Boston College. He received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. He did his undergraduate work at the University of New England where he recently received the distinguished Alumni Achievement Award. He also holds a Master’s degree in genetics from Illinois State University, Normal, IL. Thomas Seyfried served with distinction in the United States Army’s First Cavalry Division during the Vietnam War, and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine, and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society. Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro. Dr. Seyfried has over 170 peer-reviewed publications and is author of the book, Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press). His full list of peer-reviewed publications can be found on PubMed (http://www.ncbi.nlm.nih.gov/pubmed). The link to his professional web page follows (http://www.bc.edu/schools/cas/biology/facadmin/seyfried.html).



Dr. Jeff Volek is a registered dietitian and professor in the Department of Human Sciences at the Ohio State University. For the last two decades he has been performing cutting edge research elucidating how humans adapt to diets restricted in carbohydrate with a dual focus on clinical and performance applications. His work has contributed to the existing robust science of ketones and ketogenic diets, their use as a therapeutic tool to manage insulin resistance, plus their emerging potential to augment human performance and resiliency. This research indicates that that well formulated ketogenic diets result in substantial improvements in insulin resistance and the myriad of cardio-metabolic biomarkers associated with metabolic syndrome, including favorable changes in fatty acid composition and saturated fat metabolism, cholesterol and lipoprotein profiles. He has also performed seminal research on a wide range of dietary supplements (e.g., creatine, chromium, whey protein, caffeine, carnitine, HMB, etc.) that can augment performance and recovery. He has accumulated an enormous amount of laboratory and clinical data as it pertains to biomarker discovery and formulation of personalized, effective and sustainable low-carbohydrate diets. His team is currently exploring the role of nutritional ketosis induced by diet and/or supplements to: 1) reverse type-2 diabetes, 2) alter gut microbiota, 3) favorable impact tumor metabolism and health outcomes in women with advanced breast cancer, and 4) extend human physical and cognitive capabilities in elite athletes and military personnel. Dr. Volek has secured several million dollars in research funds from federal sources, industry, and foundations. He has been invited to lecture on his research nearly 200 times at scientific and industry conferences in a dozen countries. His scholarly work includes 300+ peer-reviewed scientific manuscripts and five books, including a New York Times Best Seller.



Dr. Westman received his MD from the University of Wisconsin/Madison, completed an internal medicine residency and chief residency at the University of Kentucky/Lexington, and completed a General Internal Medicine Fellowship at Duke University, which included a Masters Degree in clinical research. He has been at Duke since 1990, has over 90 peer-reviewed publications, and is currently the Director of the Duke Lifestyle Medicine Clinic. He is Chairman of the Board of the Obesity Medicine Association (formerly, the American Society of Bariatric Physicians) and a Fellow of the Obesity Medicine Association and the Obesity Society. He is author of the New York Times Bestseller The New Atkins for a New You, Cholesterol Clarity, and Keto Clarity.




Mary T. Newport, M.D. grew up in Cincinnati, Ohio, USA and was educated at Xavier University and University of Cincinnati College of Medicine, both in Cincinnati, Ohio. She is board certified in pediatrics and neonatology, and completed her training at Children’s Hospital Medical Center in Cincinnati, and Medical University Hospital in Charleston, SC. She practiced neonatology in Florida for thirty years and was founding medical director of two newborn intensive care units in the Tampa Bay area. Dr. Newport now practices at the opposite end of the spectrum, providing care for hospice patients in the Tampa Bay area of Florida. Dr. Newport is also caregiver for her husband of forty-three years, Steve, who suffers from early onset Alzheimer’s disease. They have two daughters and a grandson. She is author of Alzheimer’s Disease: What If There Was a Cure? The Story of Ketones, now in its second edition, which has been translated into French, German, and Japanese, and also author of The Coconut Oil and Low Carb Solution for Alzheimer’s, Parkinson’s and Other Diseases. Dr. Newport has been an invited speaker on this subject for symposia and conferences in the USA, Canada, France, Greece, Germany, and Japan, such as for the MCT Symposium in Tokyo, Biofach 2014, University of South Florida, the American College of Nutrition, the Institute for Human and Machine Cognition, the Fellowship in Anti-Aging and Regenerative Medicine, the International College of Integrative Medicine, Weston A. Price Foundation, and other medical and nutrition-related conferences. She has also given numerous lectures for university students and for the public.



Dr. Susan Masino is the Vernon Roosa Professor of Applied Science and Professor of Psychology and Neuroscience at Trinity College. Her laboratory uses electrophysiology, behavior and pharmacology to understand the dynamic regulation of brain activity. Her research interests span among metabolism, health and disease, and the role of adenosine in ketogenic diet therapy is a major focus. In addition to her research, Dr. Masino is dedicated to educational, environmental and public policy issues affecting brain health.





Stephanie Ciarlone is a Graduate Research Assistant in the Department of Molecular Pharmacology and Physiology at the University of South Florida (USF). She holds a Bachelor’s degree in Biology, Psychology, and Health Sciences from Guilford College in Greensboro, NC, and a Master’s degree in Medical Sciences from USF. During her time as a graduate student she has served on the Executive Board of the Association for Medical Sciences Graduate Students from 2012 – 2015, holding the position of Vice President during the 2014 – 2015 academic year. She is currently completing her PhD in the laboratory of Dr. Edwin Weeber, where her research focuses on therapeutic options for Angelman syndrome with an emphasis on seizure treatment. Her findings have been presented at the annual Society for Neuroscience conference, where she recently received the 2015 SFN Trainee Professional Development Award.



Dr. Adam Hartman received his MD from Northwestern University Medical School. After completing a residency in Pediatrics in the National Capital Uniformed Services Pediatric Residency Program, he served as a general pediatrician in the US Navy for five years (the last as division head of general pediatrics at Naval Medical Center San Diego). He completed his residency in pediatric neurology and a fellowship in clinical neurophysiology/pediatric epilepsy, both at Johns Hopkins. Now an Associate Professor at Johns Hopkins, Dr. Hartman focuses on treating children with medically intractable epilepsy. In the lab, he studies metabolism-based antiseizure treatments.



Miriam Kalamian is a nutrition consultant and educator specializing in the implementation of ketogenic therapies, primarily for individuals with cancer. She earned her Master’s in Education (EdM) from Smith College and her Master’s in Human Nutrition (MS) from Eastern Michigan University. She is board certified in nutrition by the Board for Certification of Nutrition Specialists. In 2009-2010, she developed and implemented a low-carbohydrate lifestyle intervention for children and teens (BMI >99th percentile) at the South Valley Child and Family Center in Hamilton, Montana. In 2010, she formed Dietary Therapies LLC. She has served as a resource for the MaxLove Project, a nonprofit advocacy and information group for families of children with cancer. Miriam’s current work demonstrates passion and competency in adapting ketogenic therapies to accommodate the diverse and often complex needs of individuals. Specifics include: 1) identifying and addressing relative contraindications and comorbidities that may interfere with initiating or maintaining a ketogenic diet, 2) developing a personalized plan for each individual that includes diet modifications and ketone supplementation as adjuncts to conventional and alternative therapies, and 3) problem-solving complex social, emotional and environmental issues that impede dietary compliance. Beyond cancer, Miriam integrates metabolic strategies and lifestyle modifications into a therapeutic approach that optimizes health outcomes in a broad spectrum of conditions that are currently considered intractable, including age-related, neurodegenerative and bariatric diseases. To that end, she is committed to participating in collaborations that lead to the development and dissemination of best-practice guidelines for ketogenic therapies.



Dr. Angela Poff is a Research Associate in the Department of Molecular Pharmacology and Physiology at the University of South Florida in Tampa, FL. She holds a Bachelor’s degree in Biochemistry and Molecular Biology from Hendrix College in Conway, AR. She completed her graduate work at the University of South Florida where she earned a Master’s degree and Ph.D. in Medical Sciences. During that time, Angela served on the Executive Board of the Association for Medical Sciences Graduate Students at USF from 2010 – 2014, serving as President of the board from 2012 – 2013. Angela worked as a postdoctoral research scholar in the Department of Molecular Pharmacology and Physiology at USF from 2014 – 2015. Her research focuses on the development and characterization of metabolic-based, non-toxic therapies for cancer and neurological disorders. She has presented her work at many national and international scientific conferences, including the Keystone Symposia on Tumor Metabolism, Federation of American Societies for Experimental Biology, and the Global Symposium on Ketogenic Therapies. Angela is passionate about teaching and worked as an adjunct professor at Hillsborough Community College in Tampa where she instructed night classes in Anatomy and Physiology during her doctoral and postdoctoral tenure. She currently works as an adjunct professor in the Department of Health Sciences and Human Performance at the University of Tampa where she teaches a Master’s course on Cellular Bioenergetics and Metabolism. In her free time, she enjoys spending time with her husband, Franklin, and her two dogs and two cats.



Brent A. Reynolds, Ph.D. attended the University of Calgary where he received his M.Sc. and Ph.D. in 1989 and 1994, respectively. While working of his Ph.D. thesis Reynolds’ discovered the existence of stem cells in the adult mammalian brain, a finding that overcame a century old dogma that the mature brain did not have the capacity to repair itself. After graduating Reynolds co-founded the first neural stem cell company (NeuroSpheres, Ltd.) where he was a Director and VP-Research. Here he developed a strong patent portfolio in the neural stem cell field developing and protecting protocols related to the application of stem cell technology in brain repair. Today, these patents and technology have been licensed to numerous biotechnology companies that are testing the efficacy in over half a dozen clinical trials for diseases such as spinal cord injury, stroke, ALS and pediatric disorders. After a brief hiatus, where Reynolds studied and practiced Chinese Medicine, he returned to industry and assisted in the development and launching of several products in the stem cell field while working in Vancouver, Canada. In 2004 Reynolds returned to academic science as a Professor at the Queensland Brain Institute at the University of Queensland in Australia where he continued to refining the application of neural stem cells for repairing the damaged brain. In 2008, Reynolds’ was recruited to the Dept. of Neurosurgery at the University of Florida and has focused his efforts on studying aggressive pediatric and adult brain cancer and developing novel translational approaches to combat this lethal disease. Working with a multidisciplinary group of scientists the team is taking the unique approach that cancer can be managed as a chronic disease by applying the principles that have been used in ecology to manage wildlife and pest populations. Based on the lessons learned over the past 80 years by ecologists, the team is focused on using multimodal low toxicity therapeutics to enforcing a stable tumor population that exists below a threshold that has any harmful effects. Reynolds has more than 70 publications including papers in Science, Nature and Cell with several manuscripts receiving over 1000 citations. In addition, he is an inventor on 18 granted US patents and numerous patent applications. Reynolds is currently an Associate Professor in the Dept. of Neurosurgery at the University of Florida, Adjunct Professor at the University of New South Wales, Sydney, Australia, an Honorary Professor at the Queensland Brain Institute, Australia and Program Director for StepAhead, Australia. NIH, NHMRC and numerous foundations have funded his lab.



Adrienne C. Scheck, PhD, is an Associate Professor at the Barrow Neurological Institute in Phoenix Arizona. She is also an Adjunct Professor in the School of Life Sciences at Arizona State University and an Associate Investigator in the Cancer Biology Program at the Arizona Cancer Center of the University of Arizona. Dr. Scheck received her undergraduate degree from the University of Rochester in NY and her PhD from Rensselaer Polytechnic Institute in Troy, NY. After a postdoctoral fellowship in viral oncology at the Pennsylvania State College of Medicine in Hershey, Pennsylvania she moved to Memorial Sloan-Kettering Cancer Center to study AIDS-related dementia. She began her studies of brain tumors while at Sloan-Kettering and moved to the Barrow Neurological Institute in 1989. Current work in her laboratory has 2 major goals. The first is to devise novel therapeutic regimens to improve survival and minimize side effects for patients with malignant brain tumors. To this end, her laboratory has been studying the use of the ketogenic diet (KD) for the treatment of malignant brain tumors. Their work has shown that the KD reduces the growth of malignant brain tumors through a variety of mechanisms, and it potentiates the effect of radiation and temozolomide chemotherapy. These preclinical studies have led to a clinical trial for patients with glioblastoma multiforme (www.clinicaltrials.gov NCT02046187). The second main goal of her research is to identify markers that improve on the current methods of diagnosis and prognosis for this devastating disease. In addition to her love for horses, one of Adrienne’s pet projects comes from her interest in science education. Her laboratory team includes 7-10 high school students and college undergraduates. She directs a program that places high school students in research laboratories around the Phoenix area and gives Cancer Biology lectures to area high school and college students.



Dr. Boros holds a Doctor of Medicine (M.D.) degree from the Albert Szent-Györgyi School of Medicine, Szeged, Hungary since 1987. Dr. Boros is currently a Professor of Pediatrics, Endocrinology and Metabolism at the UCLA School of Medicine, investigator at the UCLA Clinical & Translational Science (CTSI) and the Los Angeles Biomedical Research Institutes, and he is also the Chief Scientific Advisor of SiDMAP, LLC. Dr. Boros is the co-inventor of the stable isotope-based dynamic metabolic profiling (SIDMAP) technology. This functional biochemistry tool is broadly used for drug testing that involves library screening, lead optimization and in vitro and in vivo phenotype profiling. The core technology involves studying natural and disease/drug induced variations in stable non-radiating harmless isotope variations among metabolites in living systems and also the use of heavy 13C or 2H (deuterium) isotope labeled substrates for the same purposes. Dr. Boros is the co-inventor of the targeted 13C and deuterium tracer fate association study (TTFAS; TDFAS) platforms. Dr. Boros trained as a house staff in his medical school in gastroenterology after receiving a research training fellowship from the Hungarian Academy of Sciences. Dr. Boros was a visiting Scholar at the Essen School of Medicine in Germany and also worked as a Research Scientist at the Ohio State University, Department of Surgery, in the historic Zollinger-Ellison laboratory. Dr. Boros is the recipient of the C. Williams Hall Outstanding Publication Award from the Academy of Surgical Research of the United States (1997), the Richard E. Weitzman Memorial Research Award from the University of California (2001), the Excellence in Clinical Research Award from the General Clinical Research Center at the Harbor-UCLA Medical Center (2004) and Public Health Impact Investigator Award of the United States Food and Drug Administration (2011). Dr. Boros serves is an associate editor for the journals Metabolic Therapeutics, Pancreas and Metabolomics and member of the Presidential Subcommittee for Hungarian Science Abroad, Hungarian Academy of Sciences, Section of Medical Sciences (V). Dr. Boros is an Academic Editor of Medicine®, a high impact weekly periodical publishing clinical and translational research papers in cancer.



Mike’s world changed dramatically when – aged 34 and without warning – he collapsed in an epileptic seizure while working at the University of Birmingham, UK. It was his first. More followed. He was diagnosed with Temporal Lobe Epilepsy and was prescribed increasing amounts of anti-epilepsy drugs. These did not reduce the seizures and came with escalating side effects. He came across Dominic D’Agostino on the internet who suggested that Mike try a dietary approach to managing the seizures, through implementing & adapting nutritional ketosis – which had previously only been administered to children with epilepsy. Eight years later, Mike continues to use this dietary approach for managing seizures, through careful combination of exercise and diet.




Dr. Eric Kossoff is a Professor of Neurology and Pediatrics at Johns Hopkins University in Baltimore, MD. He received his medical degree from SUNY at Buffalo School of Medicine in New York, followed by a residency in pediatrics at Eastern Virginia Medical School in Norfolk, Virginia. He completed a fellowship in child neurology and then pediatric epilepsy and clinical neurophysiology at The Johns Hopkins Hospital in Baltimore. He has been at Johns Hopkins since 1998. His research and clinical practice focuses on the diagnosis and treatment of childhood seizures and epilepsy, particularly treatments other than medications such as diet, neurostimulation and surgery. Currently the Medical Director of the Ketogenic Diet Center at Johns Hopkins, he is a world expert on the ketogenic diet and created the modified Atkins diet for children and adults in 2003. He is dedicated to bringing the use of diet therapies for neurologic disorders to the entire world and is the head of a Task Force within the International League Against Epilepsy to help achieve this goal. He is a coauthor of Ketogenic Diets: Treatments for Epilepsy and Other Disorders. Dr. Kossoff is also published in the fields of Sturge-Weber syndrome, the interaction between migraine and epilepsy in children, infantile spasms, Doose syndrome, and benign rolandic epilepsy. Dr. Kossoff is also very involved in teaching and mentorship and is the Director of the Pediatric Neurology Residency Program at Johns Hopkins.



Colin Champ, MD, is an oncologist and assistant professor at the University of Pittsburgh Medical Center where he heads the diet and nutrition division of the Integrative Oncology Department. His research focuses on diet, exercise, and lifestyle optimization for cancer treatment and prevention. His work has been published in many peer-reviewed journals and he has been featured by multiple media sources, including the National Institute of Health, Sanjay Gupta’s Gupta Guide on Medpage, and the Boston Globe. He is the author of Misguided Medicine and is an avid online blogger of a range of health-related topics.



Travis Christofferson is a graduate of the Montana State Honors Program in molecular biology. He received the Nelson Fellowship for “outstanding undergraduate research”, and continued graduate research in bioremediation and cancer theory culminating in an M.S. in Material Engineering and Science from the South Dakota School of Mines and Technology. He is a science writer and the author of the recently released book Tripping Over the Truth: The Metabolic Theory of Cancer. The book offers a historical perspective on the reemerging metabolic theory of cancer — a theory that contends cancer is precipitated and driven by damage to mitochondria.



Jeff Bost, PAC, is a Neurosurgical Physician Assistant and Clinical Instructor in the Department of Neurosurgery at University of Pittsburgh Medical Center and Clinical Assistant Professor at Chatham University, Pittsburgh, PA. He is an associate of neurosurgeon, sports medicine specialist and nutritional expert with Dr. Joseph Maroon since 1987. Dr. Maroon and Mr. Bost have embraced the use of natural supplements in their neurosurgical practice and have written extensively on omega-3, ketones and resveratrol for various human conditions. He has presented 65 invited lectures, 55 national posters, 29 coordinated research projects, five workshops presentations, 35 refereed articles and 24 book chapter. He also co-wrote two books on the use of natural supplements, Fish Oil: The Natural Anti-Inflammatory, Basic Health Publications 2006 and The Science of Cocoa for a Healthier You: Scientific Breakthroughs about the Health Benefits of Cocoa and Chocolate, self-published 2011.



Beth Zupec-Kania is a Registered Dietitian and Nutritionist who has promoted safe and effective ketogenic therapies since 1991. She’s managed ketogenic diets in individuals with epilepsy, autism, multiple sclerosis, mitochondrial and metabolic disorders, migraine headache, various cancers, Angelman’s and Prader Willi syndrome, and Parkinson’s disease. She’s authored over 50 publications, co-organized global symposiums and is the designer of KetoDietCalculator, a web-based program for calculating ketogenic diets. Beth has provided ketogenic training to over 150 medical centers worldwide and is a nutrition consultant to The Charlie Foundation.